down arrow

Kymera Therapeutics, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US5015751044
USD
66.23
1.96 (3.05%)

Dec 04

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
11.48
22.10
7.39
3.74
25.65
10.29
47.88
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
11.48
22.10
7.39
3.74
25.65
10.29
47.88
Raw Material Cost
2.08
2.05
1.97
2.00
1.90
1.50
0.86
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.11
0.07
0.06
0.06
0.06
0.07
0.05
Selling and Distribution Expenses
17.64
16.27
16.33
15.46
17.37
14.37
14.23
Other Expenses
7.62
7.81
6.98
5.83
5.72
4.72
5.21
Total Expenditure (Excl Depreciation)
96.03
96.53
88.15
75.86
76.58
63.19
67.20
Operating Profit (PBDIT) excl Other Income
-84.60000000000001
-74.4
-80.8
-72.1
-50.9
-52.9
-19.3
Other Income
8.05
8.92
10.06
9.70
8.92
9.34
5.00
Operating Profit (PBDIT)
-74.42
-63.46
-68.72
-60.43
-40.10
-42.06
-13.45
Interest
0.11
0.07
0.06
0.06
0.06
0.07
0.05
Exceptional Items
0.00
0.00
0.00
0.00
0.00
-4.92
0.00
Gross Profit (PBDT)
9.39
20.05
5.42
1.74
23.75
8.79
47.02
Depreciation
2.08
2.05
1.97
2.00
1.90
1.50
0.86
Profit Before Tax
-76.61
-65.58
-70.75
-62.49
-42.06
-48.56
-14.37
Tax
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-76.61
-65.58
-70.75
-62.49
-42.06
-48.56
-14.37
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-76.61
-65.58
-70.75
-62.49
-42.06
-48.56
-14.37
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-76.61
-65.58
-70.75
-62.49
-42.06
-48.56
-14.37
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
971.48
786.23
835.62
892.93
684.92
711.20
394.97
Earnings per share (EPS)
-0.95
-0.82
-0.88
-0.82
-0.58
-0.69
-0.25
Diluted Earnings per share
-0.95
-0.82
-0.88
-0.82
-0.58
-0.69
-0.25
Operating Profit Margin (Excl OI)
-736.82%
-336.77%
-1092.17%
-1927.93%
-198.54%
-514.3%
-40.33%
Gross Profit Margin
-649.44%
-287.48%
-930.2%
-1616.87%
-156.58%
-457.44%
-28.2%
PAT Margin
-667.6%
-296.75%
-956.88%
-1670.33%
-163.98%
-472.02%
-30.01%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2025 is -47.96% vs 198.65% in Mar 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2025 is -16.77% vs 7.34% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2025 is -13.95% vs 8.12% in Mar 2025

stock-summary

Interest

QoQ Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025

Compare Quarterly Results Of Kymera Therapeutics, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
11.48
0.00
11.48
Other Operating Income
0.00
0.00
0.00
Total Operating income
11.48
0.00
11.48
Raw Material Cost
2.08
0.40
1.68
420.00%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
22.50
-22.50
-100.00%
Power Cost
0
0
0.00
Manufacturing Expenses
0.11
0.00
0.11
Selling and Distribution Expenses
17.64
17.14
0.50
2.92%
Other Expenses
7.62
3.31
4.31
130.21%
Total Expenditure (Excl Depreciation)
96.03
73.17
22.86
31.24%
Operating Profit (PBDIT) excl Other Income
-84.56
-73.17
-11.39
-15.57%
Other Income
8.05
7.14
0.91
12.75%
Operating Profit (PBDIT)
-74.42
-65.62
-8.80
-13.41%
Interest
0.11
0.00
0.11
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
9.39
-0.40
9.79
2,447.50%
Depreciation
2.08
0.40
1.68
420.00%
Profit Before Tax
-76.61
-66.02
-10.59
-16.04%
Tax
0.00
0.07
-0.07
-100.00%
Provisions and contingencies
0
0
0.00
Profit After Tax
-76.61
-66.10
-10.51
-15.90%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-76.61
-66.10
-10.51
-15.90%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-76.61
-66.10
-10.51
-15.90%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
971.48
619.40
352.08
56.84%
Earnings per share (EPS)
-0.95
-1.13
0.18
15.93%
Diluted Earnings per share
-0.95
-1.13
0.18
15.93%
Operating Profit Margin (Excl OI)
-736.82%
0.00%
0.00
-736.82%
Gross Profit Margin
-649.44%
0.00%
0.00
-649.44%
PAT Margin
-667.60%
0.00%
0.00
-667.60%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1.15 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -47.96% vs 198.65% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -55.08% vs 55.15% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit -7.66 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -16.77% vs 7.34% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -81.95% vs -8.51% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) -8.25 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -13.95% vs 8.12% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -68.37% vs -15.29% in Jun 2024

Quarterly - Interest
Interest 0.01 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -736.82%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."